The global insulin pumps market reached a value of US$ 4.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2027, exhibiting a CAGR of 6.5% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Insulin pumps are small computerized medical devices that can be clipped on to a belt, pocket or hidden under the clothes. The pump is used to deliver controlled doses of insulin inside the body at regular intervals, depending upon the consumer’s basal and bolus rate, to control the rise in blood glucose levels. It operates through a needle and a flexible catheter that is used to insert insulin directly into the fatty tissue, which is then taped and secured in place. Insulin pumps assist individuals suffering from type 1 and type 2 diabetes by providing them flexibility in food options and eating schedules and reduces the number of injection administrations.

The increasing prevalence of diabetes across the globe and rising health awareness are the key factors for market growth. Modernization of economies has significantly enhanced the occurrence of several lifestyle diseases, especially diabetes. This is further augmented by changing dietary preferences and dependency on ready-to-eat packaged food containing artificial ingredients and preservatives. Since diabetes can trigger the occurrence of other chronic conditions such as kidney failure, stroke, paralysis and blindness, manufacturers are increasingly emphasizing on creating adaptive and affordable devices. Additionally, due to the development of highly accurate glucose sensors and blood monitoring devices, the demand for efficient insulin pumps has also increased. Furthermore, factors such as rising per capita expenditure on healthcare services and increasing research and development for improving the functioning of insulin pumps have also contributed to market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global insulin pumps market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product type and distribution channel.

Breakup by Product Type:

Insulin Pumps
Tethered Pumps
Disposable/Patch Insulin Pumps
Insulin Pump Supplies and Accessories
Infusion Set Insertion Devices
Insulin Reservoirs/Cartridges

Breakup by Distribution Channel:

Hospital Pharmacy
Retail Pharmacy
Online Sales
Diabetes Clinics/ Centers
Others

Breakup by Region:

North America
Europe
Asia Pacific
Middle East and Africa
Latin America

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Animus Corp., Medtronics Inc., Insulet Corp., Roche Diagnostics, Cellnovo Ltd., Asante, Nipro Diagnostic Inc., Tandem Diabetes Care Inc., Sooil Development Co. Ltd., Ypsomed, etc. Key Questions Answered in This Report:

How has the global insulin pumps market performed so far and how will it perform in the coming years?
What are the key regional markets in the global insulin pumps industry?
What has been the impact of COVID-19 on the global insulin pumps industry?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the global insulin pumps industry?
What are the key driving factors and challenges in the global insulin pumps industry?
What is the structure of the global insulin pumps industry and who are the key players?
What is the degree of competition in the global insulin pumps industry?